NL-OMON32379尚未招募4 期
Treatment of anal intraepithelial neoplasia in HIV-positive patients, a triple-arm randomized clinical trial - Treatment of AIN in HIV+ patients
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patient is * 18 years of age
- •- Patient has a proven HIV infection
- •- Patient is MSM or woman.
排除标准
- •- History of anal carcinoma
- •- History of chronic bowel disease
- •- Life expectancy < 12 months
- •- Pregnancy or lactation
- •- Active i.v. drug use
研究者
相似试验
进行中（未招募）
不适用
Treatment of anal intraepithelial neoplasia in HIV-positive patients, a triple-arm randomized clinical trialEUCTR2007-006277-92-NLAcademic Medical Center, department of infectious diseases
尚未招募
不适用
Treatment of anal intraepithelial neoplasia in HIV-positive patients, a triple-arm randomized clinical trialAnal intraepithelial neoplasiaAnale intraepitheliale neoplasieNL-OMON25252AMCPostbus 226601100 DDAmsterdam150
已完成
不适用
A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ PatientsHIVNCT01946009Fundacion SEIMC-GESIDA20
进行中（未招募）
不适用
Treatment of genital warts with Interferon alpha-2b Cream: a randomized, double blind, placebo-controlled studyEUCTR2005-000162-40-DEHelix Product Development (Ireland) Limited120
进行中（未招募）
不适用
Treatment of genital warts with Interferon alpha-2b Cream: a randomized, double blind, placebo-controlled studyEUCTR2005-000162-40-SEHelix Product Development (Ireland) Limited120